Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma - Gigante, E; Hobeika, C; Le, Bail B (Liver Cancer, 2022)
et al.